Cargando…
Adipose-derived stem cells ameliorate atopic dermatitis by suppressing the IL-17 expression of Th17 cells in an ovalbumin-induced mouse model
BACKGROUND: Mesenchymal stem cells (MSCs) have therapeutic potential for atopic dermatitis (AD) owing to their immunoregulatory effects. However, the underlying mechanisms associated with the therapeutic efficacy of MSCs on AD are diverse and related to both cell type and delivery method. OBJECTIVES...
Autores principales: | Guan, Jingyan, Li, Yibao, Lu, Feng, Feng, Jingwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900338/ https://www.ncbi.nlm.nih.gov/pubmed/35255962 http://dx.doi.org/10.1186/s13287-022-02774-7 |
Ejemplares similares
-
The Role of Th17-Related Cytokines in Atopic Dermatitis
por: Sugaya, Makoto
Publicado: (2020) -
The role of heterodimer IL-17-A/F in atopic dermatitis
por: Krzysiek, Joanna, et al.
Publicado: (2022) -
A possible role for IL-17A in establishing Th2 inflammation in murine models of atopic dermatitis
por: Dhingra, Nikhil, et al.
Publicado: (2014) -
Neonatal-derived IL-17 producing dermal γδ T cells are required to prevent spontaneous atopic dermatitis
por: Spidale, Nicholas A, et al.
Publicado: (2020) -
Beneficial effects of melittin on ovalbumin-induced atopic dermatitis in mouse
por: Kim, Woon-Hae, et al.
Publicado: (2017)